Oct 2026· Surgical and Experimental Pathology· Vol 9· 0 citations· 14 references
TL;DR
This case illustrates the clinicopathological features of ASC, alongside a dMMR immunoprofile that may carry therapeutic relevance given the efficacy of immune checkpoint inhibitors in MSI-high colorectal tumors, and underscores the importance of correctly recognizing the VENTANA M1 clone-specific MLH1 aberrant staining pattern.
Abstract
Adenosquamous carcinoma (ASC) is a rare histological subtype of colorectal cancer (CRC) associated with a poor prognosis. Some studies suggest a distinct molecular profile, including a possibly higher frequency of mismatch repair deficiency (dMMR), PD-L1 overexpression, and KRAS mutations, although data on dMMR remain conflicting. With recent advances in CRC therapeutics, molecular characterization of rare histological subtypes has become increasingly important. Here, we report a case of colorectal ASC with dMMR and an aberrant clone dependent MLH1 immunohistochemical staining pattern, and we review the literature on this rare neoplasm. We report the case of a 64-year-old woman who presented with a three-month history of worsening abdominal pain and recent-onset hematochezia. Abdominal CT revealed a large mass involving the right colon. She underwent a total pelvic exenteration. Histopathology showed a high-grade, poorly differentiated tumor with mixed glandular and squamous components, staged as pT4b pN1a. Immunohistochemistry confirmed both glandular and squamous differentiation. Mismatch repair protein analysis showed loss of PMS2 expression and a granular, dot-like MLH1 staining pattern—interpreted as loss of expression and consistent with a known clone-dependent staining pattern—while MSH2 and MSH6 were retained, suggestive of a dMMR phenotype. The patient received mFLOX chemotherapy but died four months postoperatively due to disease-related complications. This case illustrates the clinicopathological features of ASC, alongside a dMMR immunoprofile that may carry therapeutic relevance given the efficacy of immune checkpoint inhibitors in MSI-high colorectal tumors. The findings also underscore the importance of correctly recognizing the VENTANA M1 clone-specific MLH1 aberrant staining pattern, as misinterpretation could falsely suggest isolated PMS2 loss and trigger unnecessary germline testing for Lynch syndrome. Given the rarity of ASC and its limited molecular characterization, accurate MMR status assessment remains critical for guiding treatment decisions and avoiding diagnostic pitfalls.
A rare case of a 29-year-old female with EPCAM-mutated LS presenting as colonic adenocarcinoma with neuroendocrine-like rosette formation is reported, introducing the concept of a possible pseudoendocrine carcinoma arising in an epithelial malignancy.
Arghya Bandyopadhyay, Asmita Chakrabarti, Ambalika Mondal et al.· Indian Journal of Pathology...· 0 citations
A case of an aggressive colorectal adenocarcinoma with gastric/pancreatobiliary-type differentiation in a young adult highlights a rare immunophenotypic subtype of colorectal adenocarcinoma that mimics gastric or pancreatobiliary differentiation.
Michail Skandalakis, Georgios Kaklamanis, Lampros Siozos et al.· Case Reports in Emergency Su...· 0 citations
Primary large cell neuroendocrine carcinoma (LCNEC) of the bladder is an extremely rare and highly aggressive malignancy with a poor prognosis, bringing major challenges to clinical diagnosis and treatment. We report the case of a 77-year-old man who presented with recurrent gross hematuria for more than 8 months, acco...
Yue-Zu He, Hua-Zheng Kong, Cui-Juan-Cui Zhang et al.· Journal of Visualized Experi...· 0 citations
Poorly cohesive carcinoma of the gallbladder is a very rare, often incidental finding. We present a 67-year-old woman with a clinical diagnosis of chronic calculous cholecystitis who underwent elective laparoscopic cholecystectomy. Histopathology revealed a poorly cohesive carcinoma with focal abortive glandular format...
Learta Veliu, V. Janevska· Scholars Journal of Medical...· 0 citations
BackgroundSMARCA4 genetic alterations have been associated with aggressive neoplasms in various organs. In the uterus, SMARCA4-deficiency has been reported rarely, typically presenting as undifferentiated uterine sarcoma with a poor prognosis and younger age onset. The spectrum of SMARCA4-driven uterine tumors has rece...
Fiorella Rosas Chávez, Brenda Baltodano, Fang Fan et al.· International Journal of Sur...· 0 citations